Company Filing History:
Years Active: 2020-2023
Title: Till Wenger: Innovating Cell Culture Technology in Ulm, DE
Introduction
Till Wenger is a remarkable inventor based in Ulm, Germany, whose work in the field of cell culture technology has led to significant advancements in biopharmaceutical production. With a total of two patents to his name, Wenger has contributed to improving systems that enhance the yield of therapeutic proteins, paving the way for more efficient biomanufacturing processes.
Latest Patents
Wenger's latest patents focus on mammalian cells designed for producing secreted proteins. His innovative approach involves the knockdown of activating transcription factor 6 beta (ATF6B) or the combination of ceramide synthase 2 (CERS2) and TBC1 domain family member 20 (TBC1D20) proteins, which are pivotal for the cellular secretion pathway. This downregulation results in enhanced secretion of biopharmaceutically relevant products generated in mammalian cells. His patent includes methodologies for producing these specialized mammalian cells and their applications in increasing the yield of recombinant secreted therapeutic proteins, marking a significant contribution to the biotechnology sector.
Career Highlights
Wenger is associated with Boehringer Ingelheim International GmbH, a prominent company in the healthcare and pharmaceutical domain. His role at the company allows him to work at the forefront of innovative biopharmaceutical research, leveraging his expertise in cell culture technology to drive meaningful results in product development and quality enhancement.
Collaborations
Throughout his career, Till Wenger has collaborated with notable colleagues such as Monilola Olayioye and Angelika Hausser. These partnerships have contributed to the pioneering research that enhances the capabilities of mammalian cells, leading to improved therapeutic outcomes and setting new standards in the industry.
Conclusion
Till Wenger's contributions to cell culture technology exemplify the innovative spirit necessary for advancements in biopharmaceutical production. As he continues to build on his success with impactful patents and fruitful collaborations, his work is poised to deliver substantial benefits to the healthcare sector, highlighting the importance of research and development in improving therapeutic protein production.